Generation of actionable, cancer-specific neoantigens from KRAS(G12C) with adagrasib
Maso, L., Rajak, E., Hattori, T., Hu, Z., Koide, A., Neel, B., Koide, S.To be published.
Experimental Data Snapshot
wwPDB Validation   3D Report Full Report
Entity ID: 1 | |||||
---|---|---|---|---|---|
Molecule | Chains | Sequence Length | Organism | Details | Image |
MHC class I antigen | 181 | Homo sapiens | Mutation(s): 0  Gene Names: HLA-A | ![]() | |
UniProt | |||||
Find proteins for A0A6B7HGG7 (Homo sapiens) Explore A0A6B7HGG7  Go to UniProtKB:  A0A6B7HGG7 | |||||
Entity Groups   | |||||
Sequence Clusters | 30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity | ||||
UniProt Group | A0A6B7HGG7 | ||||
Sequence AnnotationsExpand | |||||
|
Find similar proteins by: Sequence | 3D Structure
Entity ID: 2 | |||||
---|---|---|---|---|---|
Molecule | Chains | Sequence Length | Organism | Details | Image |
GTPase KRas, N-terminally processed | B [auth C] | 10 | Homo sapiens | Mutation(s): 1  Gene Names: KRAS, KRAS2, RASK2 EC: 3.6.5.2 | ![]() |
UniProt & NIH Common Fund Data Resources | |||||
Find proteins for P01116 (Homo sapiens) Explore P01116  Go to UniProtKB:  P01116 | |||||
PHAROS:  P01116 GTEx:  ENSG00000133703  | |||||
Entity Groups   | |||||
Sequence Clusters | 30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity | ||||
UniProt Group | P01116 | ||||
Sequence AnnotationsExpand | |||||
|
Entity ID: 3 | |||||
---|---|---|---|---|---|
Molecule | Chains | Sequence Length | Organism | Details | Image |
RM010 Fab heavy chain | C [auth H] | 116 | Homo sapiens | Mutation(s): 0  | ![]() |
Entity Groups   | |||||
Sequence Clusters | 30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity | ||||
Sequence AnnotationsExpand | |||||
|
Entity ID: 4 | |||||
---|---|---|---|---|---|
Molecule | Chains | Sequence Length | Organism | Details | Image |
RM010 Fab light chain | D [auth L] | 109 | Homo sapiens | Mutation(s): 0  | ![]() |
Entity Groups   | |||||
Sequence Clusters | 30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity | ||||
Sequence AnnotationsExpand | |||||
|
Funding Organization | Location | Grant Number |
---|---|---|
National Institutes of Health/National Cancer Institute (NIH/NCI) | United States | -- |